Results 111 to 120 of about 14,325 (202)

Combination of ADAM17 knockdown with eplerenone is more effective than single therapy in ameliorating diabetic cardiomyopathy

Frontiers in Pharmacology
BackgroundThe renin-angiotensin-aldosterone system (RAAS) members, especially Ang II and aldosterone, play key roles in the pathogenesis of diabetic cardiomyopathy (DCM).
Lin Xie, Dejin Zang, Jianmin Yang, Fei Xue, Wenhai Sui, Yun Zhang, Yun Zhang   +6 more
doaj   +1 more source

Eplerenone: A Selective Aldosterone Receptor Antagonist (SARA) [PDF]

, 2001
John A. Delyani, Ricardo Rocha, Chyung S. Cook, Dwain Tolbert, Stuart Levin, Barbara Roniker, Diane L. Workman, Yuen‐lung L. Sing, Brian Whelihan   +8 more
openalex   +1 more source

OPTIMIZATION, FORMULATION AND CHARACTERIZATION OF NANO BASED TDDS OF EPLERENONE

, 2023
Shinde Ramesh Vithoba, Malarkodi Velraj
openalex   +2 more sources

Тривале спостереження за хворими на гострий інфаркт міокарда при використанні антагоністів альдостерону [PDF]

, 2013
Проведено аналіз віддалених результатів використання антагоністів альдостерону (спіронолактону та еплеренону) у комплексному лікуванні хворих на інфаркт міокарда з серцевою недостатністю.
Гулага, Ольга Ігорівна, Полянська, Оксана Степанівна, Тащук, Віктор Корнійович   +2 more
core  

Who approves/pays for additional monitoring? [PDF]

, 2019
Major considerations in the provision of healthcare are availability, affordability, accessibility, and appropriateness, especially in the setting of heart failure where disease burden is growing, developments have been rapid and newer biomarkers ...
Adamson, Albert, Atherton, Biering-Sørensen, Boriani, Bristow, Consolo, Cotter, Cotter, Cowie, Cristiana Vitale, Dan, Di Nardo, Dierckx, Dovancescu, Filippatos, Gensini, Giuseppe M C Rosano, Gruson, Harjola, Ilaria Spoletini, Koehler, Kubica, Lefler, Lopatin, Magnussen, Martinson, Masson, McDonald, McDonald, Mollace, Niessner, Olivier, Pellicori, Raatikainen, Raj, Rosano, Rosano, Rosano, Rosano, Salmonson, Swedberg, Tamargo, Vitale, Vonbank, Zannad, Čelutkienė   +46 more
core   +1 more source

CONFIDENCE in the safety and efficacy of dual therapy with an SGLT‐2 inhibitor and finerenone in patients with chronic kidney disease and type 2 diabetes

Diabetes, Obesity and Metabolism, Volume 27, Issue 11, Page 6097-6100, November 2025.
Panagiotis I. Georgianos, Theocharis Koufakis, Spyridon Arampatzis, Vassilios Liakopoulos   +3 more
wiley   +1 more source

Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells [PDF]

, 2017
Vascular calcification resulting from hyperphosphatemia is a major determinant of mortality in chronic kidney disease (CKD). Vascular calcification is driven by aldosterone-sensitive osteogenic transformation of vascular smooth muscle cells (VSMCs).
Alesutan, Ioana, Castor, Tatsiana, Feger, Martina, Kratschmar, Denise V., Mia, Sobuj, Sacherer, Michael [u.a.], Voelkl, Jakob   +6 more
core   +1 more source

#4590 A PROSPECTIVE STUDY OF EPLERENONE IN THE TREATMENT OF PATIENTS WITH GLOMERULONEPHRITIS [PDF]

, 2023
Marios Papasotiriou, Georgia Andriana Georgopoulou, Adamantia Bratsiakou, Theodoros Ntrinias, Dimitrios Goumenos, Evangelos Papachristou   +5 more
openalex   +1 more source

Missed opportunities: low use of evidence-based treatment with eplerenone after myocardial infarction - a nationwide study [PDF]

, 2013
Siv Mari Berger, Morten Schou, Michelle Schmiegelow, Anna‐Karin Numé, Stefan Christensen, L Koeber, Christian Torp‐Pedersen, Gunnar Gislason   +7 more
openalex   +1 more source

Supplementary Figure 6 from Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100

, 2023
Juliet Richards, Ai Chiin Lim, C. R. M. Hay, Angela E. Taylor, Anna Wingate, Karolina Nowakowska, Carmel Pezaro, Suzanne Carreira, Jane Goodall, Wiebke Arlt, Iain J. McEwan, Johann S. de Bono, Gerhardt Attard   +12 more
openalex   +1 more source